Budapest (PRWEB) September 14, 2005
For too long Psoriasis sufferers have had to cope with bothersome and embarrassing symptoms, including itchiness, irritation and desquamation (peeling). OptodermaÂ® Cellular Memorizer has clinically proven results without the side-effects caused by many conventional treatments. ItÂs simple, easy-to-use system restores the natural functions of the skin, bringing relief to millions.
In 2004, Optoderma Cellular Memorizer was clinically tested on long-term psoriasis sufferers in the Aeskulap Hospital in Brunnen, Switzerland (Swiss Centre for Clinical Holistic Medicine). Additional control tests in Germany, Holland, Hungary and Switzerland confirm its exciting results. The vast majority of test patients experienced relief from itching after only a few days. After a six-week period, a highly significant 77% of test patients reported that the symptoms had either gone, or were drastically reduced. Clinical test reports can be seen in detail on the website at http://www.optoderma.com.
Psoriasis Vulgaris is a surprisingly common illness affecting approximately 12 million people in Europe alone. Until now, skin sensitivity and the likelihood of allergies and side-effects have made effective topical treatment of psoriasis difficult. OptodermaÂ´s products are hypoallergenic and made up of natural active components, thereby circumventing the majority of these problems. A simple routine combining OptodermaÂ® Cellular Memorizer Lotion and Cream provides rapid and long-term relief. In October of this year the company will launch its hypoallergenic Scalp Gel and its Body Lotion through its existing distribution network in various European countries and through its web shop.
From its conception in early 2004, the company now delivers to over 20 European Countries, where its products are sold in pharmacies, herbal stores, skin-clinics and dermatologists. Continuing this rapid expansion, OptodermaÂ´s product range will be available throughout most European countries by the end of 2006.